Clinical Trials Arena

Congratulations to Toyna Chin, Global Director of Marketing at Novotech, for her visionary leadership in rebranding Novotech into a recognized global CRO leader! Under Toyna’s guidance, Novotech has undergone a transformative journey—positioning the company as a trusted name worldwide. Her strategic, multi-channel marketing approach has strengthened Novotech’s brand consistency and expanded its reach across key markets. Through innovative campaigns and participation in major global events like BIO and the JP Morgan Conference, Toyna’s team has elevated brand recall and attracted high-value clients, especially in the US and Europe. Learn more about Novotech’s growth journey - https://lnkd.in/e75ZTtjE

Teva Pharmaceuticals’ TEV-479 (olanzapine) has shown statistical improvement in schizophrenia symptoms in a Phase III trial. Click here for the full article - https://lnkd.in/d_mEwU9P #clinicaltrials #schizophrenia #drugdevelopment

With the US Election tomorrow, the Clinical Trials Arena team investigates how healthcare could look under a Trump or Harris administration. #USElection2024 #Trump #Harris #healthcare

Endevica Bio has launched a new spin-off company, Abisati, to accelerate its obesity candidate into clinical trials. CEO of Endevica Bio and Abisati, Russell Potterfield, said: “We are so excited about the prospects for a drug that could be life-changing for millions of people suffering from obesity. Our peptide has the potential to help patients lose weight without the side effects such as nausea and vomiting seen with drugs now on the market and without the ‘bounce back’ weight gain that can happen after patients discontinue medication.” Click here for the full article - https://lnkd.in/dQFVD5_m #clinicaltrials #obesitydrugs #drugdevelopment

The World Health Organization’s (WHO) new framework aimed at strengthening clinical trial systems addresses a global issue of “major research waste”, according to Vasee Moorthy, senior advisor of research and development at World Health Organization. Click here for the full article - https://lnkd.in/dz_mu-RU #clinicaltrials #researchwaste Outsourcing in Clinical Trials Event Series

California-based clinical development company Medable, Inc has announced a partnership with technology giant Google Cloud to bring the company’s digital, decentralised clinical trial platform to the Google Cloud Marketplace. Michelle Longmire, co-founder, and CEO of Medable, said: “This alliance provides life sciences companies with Medable’s cutting-edge clinical development technology powered by Google Cloud through Google Cloud Marketplace. The collaboration will enable scaled and seamless adoption of Medable solutions by Google Cloud users, providing life sciences companies with platform capabilities proven to improve patient access to trials and accelerate critical development efforts, globally.” Dai Vu, managing director of Google Cloud Marketplace, said: “Bringing Medable’s platform to Google Cloud Marketplace will help customers quickly deploy, manage, and expand their use of the AI-driven clinical trial platform on Google Cloud’s trusted, global infrastructure.” Click here for the full article - https://lnkd.in/dykyTtXA #clinicaltrials #clinicalresearch #cloudtechnology #DCTs #decentralizedclinicaltrials #decentralizedtrials #ai #aiinhealthcare

Roche has presented new late-breaking data from a prospective trial showing that its Elecsys amyloid plasma panel can rule out Alzheimer’s disease with a high negative predictive value (NPV) of 96.2%. Click here for the full article - https://lnkd.in/dwfpjW-V #clinicaltrials #alzheimers #pharma

Despite stringent European Union (EU) laws governing smaller medical device and pharma companies, the DACH region can be an attractive place to conduct clinical trials, according to industry leaders. Andrea Sauerland, senior vice-president of clinical operations at Endotronix, Enrico Perfler, founder of medtech contract research organisation (CRO) 1MED SA and Ina Meyer, study and site operations country manager for Switzerland at Novartis were speaking at our Annual Outsourcing in Clinical Trials DACH 2024 event which is taking place in Zurich, Switzerland, on 29–30 October. Click here for the full article - https://lnkd.in/gWKMSeT5 #clinicaltrials #clinicaloperations #contractresearch #CRO #medtech Outsourcing in Clinical Trials Event Series Arena International Events Group #pharma

Questions remain over costs and the participant experience when it comes to community-based research sites. However, conducting research in the community could create a more cost-effective and positive trial experience with fewer participant dropouts. Learn more in this article form PCM TRIALS - Quality Mobile Research - https://lnkd.in/d5S69jSR #clinicaltrials #clinicalresearch #DCTs #decentralizedclinicaltrials

Moderna and MSD have initiated a Phase III clinical study to evaluate mRNA-4157 (V940), an investigational individualised neoantigen therapy, in combination with Keytruda to treat non-small cell lung cancer (NSCLC). MSD Research Laboratories oncology and global clinical development senior vice-president and head Dr Marjorie Green said:“We are pleased to expand the INTerpath clinical trial programme with Moderna, evaluating V940 (mRNA-4157), a promising new modality, in combination with Keytruda to pursue meaningful advances for lung cancer and bring more options to patients with earlier stages of disease, where we potentially can have the most impact.” Click here for the full article - https://lnkd.in/dJC3_uCf #clinicaltrials #keytruda #lungcancer #oncology #mRNA